Advertisement
Home Tags Diabetes: Misc.

Tag: Diabetes: Misc.

For patients with diabetes mellitus undergoing percutaneous coronary intervention

High Lipoprotein(a) Predicts Cardiac Events in DM With PCI

High Lp(a) independent predictor of cardiac death, acute coronary syndrome in multivariate analysis
For women with diabetes who are using hormonal contraception

Low Thromboembolism Risk for Contraceptive Use in Diabetes

Among women with diabetes, lowest rates seen with use of intrauterine and subdermal contraceptives
Variants in genes encoding proprotein convertase subtilisin-kexin type 9 and 3-hydroxy-3-methylglutarylcoenzyme A reductase are associated with almost equivalent effects on the risk of cardiovascular events and diabetes per unit decrease in low-density lipoprotein cholesterol level

Similar Effects for PCSK9, HMGCR Variant-Mediated Lower LDL

Almost equivalent effects on cardiovascular events, diabetes per unit decrease in LDL-cholesterol level

November 2016 Briefing – Diabetes & Endocrinology

Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for November 2016. This roundup includes...
In early November

As Prices Soar, ADA Calls for Access to Affordable Insulin

American Diabetes Association asks Congress to investigate the matter
Glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) are associated with increased risk of gastrointestinal adverse events

GI Adverse Events Up With GLP-1 Receptor Agonists

Risk varies based on dose, background medications, and type of GLP-1 RA
A new implantable continuous glucose monitoring system seems to be safe and accurate for diabetes

Implantable Continuous Glucose Monitoring System Safe, Accurate

>99 percent of samples in clinically acceptable error zones A and B in Clarke Error Grid Analysis
For patients with diabetes mellitus

Deferred Revascularization Tied to Poor Outcomes in Diabetes

Previous MI is effect modifier for patients with FFR-negative medically treated lesions
Medicare Part D has effectively reduced the out-of-pocket cost burden of prescription drugs for beneficiaries with diabetes

Part D Has Reduced Out-of-Pocket Rx Drug Costs in Diabetes

Decrease in proportion of Part D beneficiaries who experienced coverage gap to 40.9 percent in 2011

October 2016 Briefing – Diabetes & Endocrinology

Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for October 2016. This roundup includes...